The Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve system is indicated for patients with symptomatic heart disease due to failing (stenosed, …

Controlled, low-profile vascular access for today's transcatheter aortic valve patients. Thoughtfully designed to: *TAVI = Transcatheter Aortic Valve Implantation. 1. Nazif,et al. Real-World …

Built upon the proven SAPIEN platform, the SAPIEN 3 Ultra transcatheter heart valve is designed with your patient's future needs in mind.

2021年6月8日 · The Edwards SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Heart Valve (THV) System is a catheter-based artificial heart valve system designed to replace a diseased heart …

The Edwards SAPIEN 3 transcatheter heart valve system is indicated for use in the management of pediatric and adult patients with the following clinical conditions: Dysfunctional Right …

2023年3月18日 · The Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA transcatheter heart valve system is indicated for use in patients with heart disease due to …

The Edwards SAPIEN 3 Ultra transcatheter heart valve system is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic …

Edwards SAPIEN 3 TAVR PCI is more likely to occur in low-risk patients post-TAVR due to their longer life expectancy.1

The SAPIEN 3 TAVI Advantage For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions, and adverse …

2024年11月25日 · Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The …